The invention concerns novel nucleic acids, in particular the gene responsible for Familial Mediterranean Fever (FMF), and the corresponding protein. It further concerns probes and primers for detecting and amplifying said gene, and kits and methods for detecting FMF. It also concerns all use of the gene and the protein, in particular for therapeutic purposes.
